The Department of Health’s Expert Review of Medicines and Medical Devices Regulation panel is seeking feedback from stakeholders to inform its thinking on the regulation of complementary medicines.
The release of a chapter on complementary medicines is an addendum to a discussion paper released last year by the panel, headed by Emeritus Professor Lloyd Sansom AO. Stakeholders are being encouraged to read both the discussion paper and the chapter and make written submissions based on the questions for consideration raised in the discussion paper.
The Review will examine the Therapeutic Goods Administration’s regulatory framework and processes in respect of prescription, over-the-counter, and complementary medicines and medical devices with a view to identifying:
- areas of unnecessary, duplicative, or ineffective regulation that could be removed or streamlined without undermining the safety or quality of therapeutic goods available in Australia; and
- opportunities to enhance the regulatory framework so that Australia continues to be well positioned to respond effectively to global trends in the development, manufacture, marketing and regulation of therapeutic goods.
Stakeholders are also welcome to bring other issues that fall within the Review’s Terms of Reference to the panel’s attention. All submissions received by the due date of 8 April will be analysed and considered by the panel in formulating its recommendations to government.